# Pepsico Inc: overview

PEP · Nasdaq · CIK 77476 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/pep.md) · [Financials](/companies/pep/financials.md) · [Filings](/companies/pep/filings.md) · [Insiders](/companies/pep/insiders.md)

Latest reported revenue: [$25.27bn](/filings/0000077476-26-000048.md) for Q3 FY2026, three months to 2026-09-05, from the 10-Q filed Oct 8, 2026 (XBRL us-gaap:Revenues, accession 0000077476-26-000048).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-06-15) | Q3 FY2024 (2024-09-07) | Q1 FY2025 (2025-03-22) | Q2 FY2025 (2025-06-14) | Q3 FY2025 (2025-09-06) | Q1 FY2026 (2026-03-21) | Q2 FY2026 (2026-06-13) | Q3 FY2026 (2026-09-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [22.5](/filings/0000077476-25-000044.md) | [23.3](/filings/0000077476-25-000053.md) | [17.9](/filings/0000077476-26-000017.md) | [22.7](/filings/0000077476-26-000035.md) | [23.9](/filings/0000077476-26-000048.md) | [19.4](/filings/0000077476-26-000017.md) | [24.2](/filings/0000077476-26-000035.md) | [25.3](/filings/0000077476-26-000048.md) |
| Gross margin | % | [55.9%](/filings/0000077476-25-000044.md) | [55.4%](/filings/0000077476-25-000053.md) | [55.8%](/filings/0000077476-26-000017.md) | [54.7%](/filings/0000077476-26-000035.md) | [53.6%](/filings/0000077476-26-000048.md) | [55.2%](/filings/0000077476-26-000017.md) | [54.2%](/filings/0000077476-26-000035.md) | [54.4%](/filings/0000077476-26-000048.md) |
| Operating margin | % | [18.0%](/filings/0000077476-25-000044.md) | [16.6%](/filings/0000077476-25-000053.md) | [14.4%](/filings/0000077476-26-000017.md) | [7.9%](/filings/0000077476-26-000035.md) | [14.9%](/filings/0000077476-26-000048.md) | [16.5%](/filings/0000077476-26-000017.md) | [16.6%](/filings/0000077476-26-000035.md) | [16.9%](/filings/0000077476-26-000048.md) |
| Net margin | % | [13.7%](/filings/0000077476-25-000044.md) | [12.6%](/filings/0000077476-25-000053.md) | [10.2%](/filings/0000077476-26-000017.md) | [5.6%](/filings/0000077476-26-000035.md) | [10.9%](/filings/0000077476-26-000048.md) | [12.0%](/filings/0000077476-26-000017.md) | [12.3%](/filings/0000077476-26-000035.md) | [12.1%](/filings/0000077476-26-000048.md) |
| Diluted EPS | $ per share | [2.23](/filings/0000077476-25-000044.md) | [2.13](/filings/0000077476-25-000053.md) | [1.33](/filings/0000077476-26-000017.md) | [0.92](/filings/0000077476-26-000035.md) | [1.90](/filings/0000077476-26-000048.md) | [1.70](/filings/0000077476-26-000017.md) | [2.18](/filings/0000077476-26-000035.md) | [2.23](/filings/0000077476-26-000048.md) |
| Free cash flow | $bn | not reported | not reported | [(1.6)](/filings/0000077476-26-000017.md) | not reported | not reported | [(0.4)](/filings/0000077476-26-000017.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-25) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2025-12-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [79.5](/filings/0000077476-24-000008.md) | [86.4](/filings/0000077476-25-000007.md) | [91.5](/filings/0000077476-26-000007.md) | [91.9](/filings/0000077476-26-000007.md) | [93.9](/filings/0000077476-26-000007.md) |
| Gross margin | % | [53.3%](/filings/0000077476-24-000008.md) | [53.0%](/filings/0000077476-25-000007.md) | [54.2%](/filings/0000077476-26-000007.md) | [54.6%](/filings/0000077476-26-000007.md) | [54.1%](/filings/0000077476-26-000007.md) |
| Operating margin | % | [14.0%](/filings/0000077476-24-000008.md) | [13.3%](/filings/0000077476-25-000007.md) | [13.1%](/filings/0000077476-26-000007.md) | [14.0%](/filings/0000077476-26-000007.md) | [12.2%](/filings/0000077476-26-000007.md) |
| Net margin | % | [9.6%](/filings/0000077476-24-000008.md) | [10.3%](/filings/0000077476-25-000007.md) | [9.9%](/filings/0000077476-26-000007.md) | [10.4%](/filings/0000077476-26-000007.md) | [8.8%](/filings/0000077476-26-000007.md) |
| Diluted EPS | $ per share | [5.49](/filings/0000077476-24-000008.md) | [6.42](/filings/0000077476-25-000007.md) | [6.56](/filings/0000077476-26-000007.md) | [6.95](/filings/0000077476-26-000007.md) | [6.00](/filings/0000077476-26-000007.md) |
| Free cash flow | $bn | [7.0](/filings/0000077476-24-000008.md) | [5.6](/filings/0000077476-25-000007.md) | [7.9](/filings/0000077476-26-000007.md) | [7.2](/filings/0000077476-26-000007.md) | [7.7](/filings/0000077476-26-000007.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pep/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-21 | [Laguarta Ramon](/insiders/1630253.md) | Chairman and CEO, Director, Officer | Sale (S) | 30,000 | $135.1297 | $4.1m | [Form 4](/filings/0001630253-26-000007.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $16.02bn | 118,281,854 |  | Added +2,440,377 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $12.09bn | 89,257,968 |  | Added +450,194 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $8.18bn | 60,406,932 |  | Added +987,582 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $5.84bn | 43,113,398 |  | Added +31,052,716 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $5.03bn | 37,159,425 |  | Added +704,386 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $4.89bn | 36,096,064 |  | Added +5,885,256 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $4.73bn | 34,977,755 |  | Added +365,936 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $4.24bn | 30,596,336 |  | Reduced −4,202,596 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $3.60bn | 26,615,206 |  | Added +34,032 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $2.76bn | 20,350,877 |  | Reduced −932,824 |

## Recent filings

[All 1,827 filings](/companies/pep/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 20:30 ET | [8-K](/filings/0001104659-26-116626.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-116626 |
| 2026-10-08 | 21:57 ET | [8-K](/filings/0000077476-26-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000077476-26-000050 |
| 2026-10-08 | 21:52 ET | [10-Q](/filings/0000077476-26-000048.md) | Quarterly report, period 2026-09-05 | 0000077476-26-000048 |
| 2026-09-17 | 21:10 ET | [8-K](/filings/0000077476-26-000042.md) | 5.02 Departure or appointment of officers or directors | 0000077476-26-000042 |
| 2026-07-09 | 21:55 ET | [8-K](/filings/0000077476-26-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000077476-26-000037 |
| 2026-07-09 | 21:52 ET | [10-Q](/filings/0000077476-26-000035.md) | Quarterly report, period 2026-06-13 | 0000077476-26-000035 |
| 2026-05-22 | 20:30 ET | [8-K](/filings/0001104659-26-065758.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065758 |
| 2026-05-08 | 20:19 ET | [8-K](/filings/0000077476-26-000024.md) | 5.07 Shareholder vote results | 0000077476-26-000024 |
| 2026-04-16 | 22:01 ET | [8-K](/filings/0000077476-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000077476-26-000019 |
| 2026-04-16 | 21:56 ET | [10-Q](/filings/0000077476-26-000017.md) | Quarterly report, period 2026-03-21 | 0000077476-26-000017 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 27, 2025](/filings/0000077476-26-000007.md), filed Feb 3, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 77476
- Tickers: PEP
- Exchange: Nasdaq
- SIC code: 2080 Beverages
- State of incorporation: NC
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.